Morgan Stanley cuts India's GlaxoSmithKline Pharma to 'under-weight' | business | Hindustan Times
Today in New Delhi, India
Apr 30, 2017-Sunday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Morgan Stanley cuts India's GlaxoSmithKline Pharma to 'under-weight'

Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.

business Updated: Feb 28, 2013 10:25 IST

Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.

GlaxoSmithKline's shares are also constrained by its pricing policy and "full" valuations, the broker added.

Is Your Couch Making You Cough?
Promotional Feature